FDA approves a second Alzheimer's drug that can modestly slow disease – NPR
Business News FDA approves a second Alzheimer’s drug that can modestly slow disease NPR FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNN Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment The Wall Street Journal Alzhiemer’s drug Kisunla from Eli Lilly gains FDA approval USA TODAY FDA approves Eli Lilly’s Alzheimer’s drug that slows […]
